Skip to main content
FTRE
NASDAQ Industrial Applications And Services

Fortrea Reports Significant Q2 Operational Turnaround with Reduced Net Loss and Positive Cash Flow, Amidst Ongoing CFO Legal Battle

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Neutral
Importance info
8
Price
$20.4
Mkt Cap
$1.93B
52W Low
$5.265
52W High
$21.39
52W Position info
287% above low
Off High info
4.6% below high
Rel. Volume info
2.1× avg
Market data snapshot near publication time

FTRE has more than doubled off its 52-week low of $5.265 on elevated volume (2.1× avg).

Summary

Fortrea announced a strong Q2 operational turnaround with significantly reduced net losses and positive cash flow from operations, despite a revenue decline, while also detailing a legal challenge that has sidelined its new CFO.


Key Events · Earnings and Guidance · FTRE

  • Significant Q2 2026 Financial Improvement

    Net loss for Q2 2026 drastically reduced to $(13.2) million, a substantial improvement from $(374.9) million in Q2 2025. Operating income also improved significantly to $14.8 million from a $(330.3) million loss in the prior year period.

  • Positive Cash Flow from Operations

    The company generated $11.9 million in cash from operating activities for the first six months of 2026, a major positive shift from using $102.4 million in cash during the same period in 2025.

  • No Goodwill Impairment in 2026

    Fortrea reported no goodwill or other asset impairments for Q2 2026, a significant contrast to the $309.1 million impairment recorded in Q2 2025.

  • CFO Sidelined by Court Order

    Newly appointed CFO Jason Knoblauch was temporarily prohibited from performing services by a court order on July 25, 2026, due to alleged violations of restrictive covenants from a former employer. David R. Smith has been appointed interim CFO.


Analysis · FTRE · Industrial Applications And Services

Fortrea Holdings Inc. reported a substantial operational turnaround in Q2 2026, significantly reducing its net loss and achieving positive cash flow from operations. This marks a strong improvement from the prior year's large losses and goodwill impairments, indicating a healthier underlying business. However, the company is simultaneously navigating a critical leadership challenge, with its newly appointed CFO sidelined by a court order due to alleged restrictive covenant violations, leading to the appointment of an interim CFO. This creates uncertainty in the finance leadership, which investors will closely watch.

At the time of this filing, FTRE was trading at $20.40 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $1.9B. The 52-week trading range was $5.27 to $21.39. This filing was assessed with neutral market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

FTRE - Latest Insights

FTRE
Jul 29, 2026, 6:38 AM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $20.66
Real-time Price: $20.40 info
Change: -$0.260 (-1%) info
Market Cap: $1.93B info
FTRE
Jul 29, 2026, 6:36 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $20.66
Real-time Price: $20.40 info
Change: -$0.260 (-1%) info
Market Cap: $1.93B info
FTRE
Jul 14, 2026, 4:05 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $18.03
Real-time Price: $20.40 info
Change: +$2.37 (+13%) info
Market Cap: $1.93B info
FTRE
Jun 26, 2026, 4:42 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $17.65
Real-time Price: $20.40 info
Change: +$2.75 (+16%) info
Market Cap: $1.93B info
FTRE
Jun 26, 2026, 7:32 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $17.35
Real-time Price: $20.40 info
Change: +$3.05 (+18%) info
Market Cap: $1.93B info